Ignite Creation Date:
2024-05-05 @ 11:26 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01331720
Status:
COMPLETED
Last Update Posted:
2011-04-08
First Post:
2011-04-06
Brief Title:
Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Study Overview
Official Title:
Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation Protocols Which Are the Most Common in Clinical Practice Using High Purified Gonadotrophins u-FSH-HP y u-hMG-HP in IVFICSI
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DESCARTES
Brief Summary:
The aim of the study is to assess the effectiveness of 5 mixed protocols of ovarian hyperstimulation with urinary gonadotrophins to achieve clinical pregnancy in females undergoing assisted reproductive techniques IVFICSI in-vitro fertilisationintracytoplasmic sperm injection
Study hypothesis mixed protocols with urinary FSH follicle-stimulating hormone and urinary hMG human menopausal gonadotropinshould be more effective than monotherapy
Study hypothesis mixed protocols with urinary FSH follicle-stimulating hormone and urinary hMG human menopausal gonadotropinshould be more effective than monotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None